CLVTCLARIVATE PLC

NYSE clarivate.com


$ 6.40 $ 0.05 (0.79 %)    

Monday, 19-Aug-2024 15:59:57 EDT
QQQ $ 481.15 $ 6.24 (1.31 %)
DIA $ 409.09 $ 2.37 (0.58 %)
SPY $ 559.11 $ 5.30 (0.96 %)
TLT $ 97.90 $ 0.45 (0.46 %)
GLD $ 231.62 $ -0.38 (-0.16 %)
$ 6.4
$ 6.36
$ 6.39 x 2,400
-- x --
$ 6.36 - $ 6.53
$ 4.97 - $ 9.61
3,787,966
na
4.63B
$ 1.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 02-27-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-07-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-10-2022 12-31-2021 10-K
12 10-28-2021 09-30-2021 10-Q
13 07-29-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 07-30-2020 06-30-2020 10-Q
18 05-04-2020 03-31-2020 10-Q
19 03-02-2020 12-31-2019 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-underweight-on-clarivate-lowers-price-target-to-5

Barclays analyst Manav Patnaik maintains Clarivate (NYSE:CLVT) with a Underweight and lowers the price target from $6 to $5.

 rbc-capital-maintains-sector-perform-on-clarivate-lowers-price-target-to-7

RBC Capital analyst Ashish Sabadra maintains Clarivate (NYSE:CLVT) with a Sector Perform and lowers the price target from $8...

 clarivate-appoints-matti-shem-tov-as-its-next-ceo-effective-august-9-2024--jonathan-gear-to-step-down-as-ceo-and-member-of-board

 Jonathan Gear, Chief Executive Officer, will step down as CEO and as a member of the Board at that time, and will transition i...

 clarivate-reaffirms-fy24-outlook-for-revenues-of-257b---267b-est-261b-adjusted-eps-070---080-est-074

"We continue to expect our full year 2024 financial results to be in the range of our existing outlook," said Jonathan ...

 clarivate-q2-2024-adj-eps-020-beats-018-estimate-sales-650300m-miss-651876m-estimate

Clarivate (NYSE:CLVT) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.18 by 11.1...

 clarivate-launches-off-x-platform-to-enhance-drug-safety-intelligence

 Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the launch of the new OFF-...

 clarivate-acquires-rowan-tels-corp-through-subsidiary-no-terms-disclosed

Rowan TELS Corp. is the provider of Rowan Patents – an integrated patent drafting and prosecution solution specially designed f...

 riot-platforms--north-face-parent-vf-corp-are-among-11-mid-cap-stocks-that-performed-the-best-last-week-july-14-july-20-are-others-in-your-portfolio

Top mid-cap stock performers: VIRT (+30%), VFC (+22%), NFE (+20%), RIOT (+16%), CLVT (+14%), AMN (+14%), BKU (+13%), MARA (+12%...

 clarivate-and-ohio-libraries-partner-to-enhance-resource-sharing-by-2025

 Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a partnership with OhioLI...

 clarivate-launches-ip-collaboration-hub-to-streamline-global-ip-management

 Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today launched the IP Collaboration Hub™ ...

 clarivate-inks-pact-with-healthwise-data-to-boost-real-world-data-offering-collaboration-enhances-patient-demographics-insight-enabling-analytical-precision-in-population-health-outcomes

Clarivate announced a strategic partnership with HealthWise Data, a leading healthcare data and analytics firm bridging the gap...

 why-is-clarivate-stock-trading-higher-premarket-monday

Clarivate Plc launched AI-enhanced Trademark Watch Analyzer at 2024 International Trademark Association Annual Meeting, connect...

 clarivate-debuts-ai-enhanced-solution-to-accelerate-trademark-watching-at-inta-2024

Providing faster and more accurate answers to critical business questions LONDON, May 20, 2024 /PRNewswire/ -- Clarivate Plc (...

 goldman-sachs-maintains-buy-on-clarivate-lowers-price-target-to-75

Goldman Sachs analyst George Tong maintains Clarivate (NYSE:CLVT) with a Buy and lowers the price target from $8.5 to $7.5.

 clarivate-q1-2024-gaap-eps-014-inline-sales-621200m-beat-614860m-estimate

Clarivate (NYSE:CLVT) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a 22.22 ...

 clarivate-unveils-epidemiology-intelligence-for-precision-patient-population-analysis

Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for p...

 clarivate-enhances-cortellis-cmc-intelligence-with-post-approval-module-to-accelerate-regulatory-success

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly en...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION